Current Valuation
$700.0M
As of February 7, 2025
Total Funding Raised
$407.3M
Across 2 rounds
Last Round
Later Stage VC

$200.0M

Last Funding
Feb 2025

Funding date

Capital Efficiency
1.72x

Valuation / Funding

Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
DateRoundAmountPost-ValuationGrowth
February 7, 2025Later Stage VC (Series C)$200.0MN/A-
August 11, 2023Later Stage VC (Series B)$155.0MN/A-
Valuation Analysis

Current Valuation Metrics

Abcuro is currently valued at $700.0M as of February 7, 2025. The company has raised a total of $407.3M in funding across 2 funding rounds.

Capital Efficiency

With a capital efficiency ratio of 1.72x, Abcuro has achieved a valuation that is 1.72 times the total capital raised.

Track Abcuro Valuation Updates

Get notified when Abcuro raises new funding or valuation changes

View 5 companies free

Create a free account to unlock Abcuro's valuation history, funding rounds, and growth metrics.

No credit card required

What is Abcuro Worth in 2026?

Abcuro is a leading private company in the Drug Discovery sector. Track Abcuro's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Abcuro Valuation is Determined

Private company valuations like Abcuro's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.